CDSCO Orders Sun Pharma to Stop Production of Ophthalmic Drugs Including Lotepred, Nepalact
Hyderabad: Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failure in its quality management system, documents reviewed by Reuters …